✦ LIBER ✦

P319 Phase II study of high-dose toremifene as first line treatment of metastatic breast cancer in patients with adjuvant aromatase inhibitor-resistance

✍ Scribed by M. Sawaki; M. Wada; Y. Sato; Y. Mizuno; H. Kobayashi; K. Yokoi; M. Yoshihara; K. Kamei; M. Ohno; T. Imai

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II clinical study of high-dose tor

✍ H. Modig; S. Borgström; I. Nilsson; G. Westman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II study of second-line treatment

✍ Flemming Hansen; Peter Møller; Torben Skovsgaard 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 216 KB

Phase I/II study of sorafenib with anast

✍ Claudine Isaacs; Pia Herbolsheimer; Minetta C. Liu; Mary Wilkinson; Yvonne Ottav 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 220 KB

Recurrent metastatic breast cancer treat

✍ Hansen, F.; Møller, P.; Skovsgaard, T. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Phase II study of single agent oral vino

✍ Mansour, Maged; Mourad, Cynthia 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 244 KB

P101 A multicenter phase II study of Epi

✍ M. De Tursi; C. Carella; E. Ricevuto; A. Gennari; C. Orlandini; A. Frassoldati; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB